U.S. FDA approves J&J\'s bladder cancer drug

U.S. FDA approves J&J's bladder cancer drug

The green signal to the drug, Balversa, makes it the first approved treatment for bladder cancer that targets a genetic alteration known as FGFR3 or FGFR2, the FDA said.REUTERS  |  April 12, 2019, 23:21 IST
U.S. FDA approves J&J's bladder cancer drug The U.S. Food and Drug Administration on Friday approved Johnson & Johnson's treatment for patients with a form of bladder cancer.

The green signal to the drug, Balversa, makes it the first approved treatment for bladder cancer that targets a genetic alteration known as FGFR3 or FGFR2, the FDA said.